Results 151 to 160 of about 23,497 (215)

Thyroid Function Screening in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy. [PDF]

J Int Assoc Provid AIDS Care
Bolas AF, Caixas U, Bogalho P, Silva-Nunes J.   +3 more
europepmc   +1 more source

HIV-1 virologic failure in the RESINA cohort: lessons from two decades of real-world data. [PDF]

Infection
Gliga S, Böhm M, Lübke N, Killer A, Hüttig F, Haberl L, Timm J, Müller C, Heger E, Büch J, Fätkenheuer G, Lehmann C, Oette M, Hower M, Knechten H, Schübel N, Esser S, Schneeweiß S, Qurishi N, Römer K, Rockstroh JK, Kaiser R, Luedde T, Jensen BO, RESINA Study Group.   +24 more
europepmc   +1 more source

Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry. [PDF]

J Antimicrob Chemother
Armenia D, Marchegiani G, Spagnuolo V, Bellocchi MC, Galli L, Clemente T, Carioti L, Lolatto R, Ferrara M, Gagliardini R, Marchetti GC, Torti C, De Socio G, Fornabaio C, Zazzi M, Castagna A, Santoro MM, PRESTIGIO Study Group.   +17 more
europepmc   +1 more source

Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon. [PDF]

Pan Afr Med J
Djoda B, Fru-Cho J, Njukeng PA, Semengue ENJ, Fokou PVT, Molimbou E, Etame NK, Wouambo RK, Wilhelm B, Dächert C, Megaptche AN, Muenchhoff M, Wade A, Van Cleaf S, Eberle J, Fokounang C, Fokam J, Keppler OT, Bosnjak O.   +18 more
europepmc   +1 more source

Drug Resistance Among Newly Diagnosed People Living with HIV-1 in Sichuan, China: A Large-Scale Population-Based Cross-Sectional Study. [PDF]

Infect Drug Resist
Li L, Zhou C, Feng L, Zhou J, Zhang Y, Li Y, Wang N, Zhou J, Ren J, Yuan F, Ye L, Yang H, Yang Y, Liang S, Yuan D.   +14 more
europepmc   +1 more source

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023. [PDF]

Open Forum Infect Dis
Asio JN, Watera C, Namayanja G, da Silva JF, Pals S, Ssemwanga D, Sanyu G, Nannyonjo M, Kaganda UK, Busobozi R, Nansumba H, Nabukenya M, Ayitewala A, Ssali M, Katureebe C, Magongo EN, Balidawa H, Nazziwa E, Ntale J, Raizes E, Zheng DP, Zeh C, Hackett S, Naluguza M, Mbidde EK, Kaleebu P.   +25 more
europepmc   +1 more source

Factors Associated With Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda. [PDF]

J Acquir Immune Defic Syndr
Nutt CT, Muyindike WR, Nanfuka V, Komukama N, Barigye IT, Kansiime L, Tumusiime J, Omoding D, Aung TN, Stuckwisch A, Hedt-Gauthier B, Hoeppner SS, Marconi VC, Moosa MS, Gupta RK, Siedner MJ, McCluskey SM.   +16 more
europepmc   +1 more source

Design and Evaluation of Next-Generation HIV Genotyping for Detection of Resistance Mutations to 28 Antiretroviral Drugs Across 5 Major Classes Including Lenacapavir. [PDF]

Clin Infect Dis
Park SY, Takayama C, Ryu J, Sattah M, Badii Z, Kim JW, Shafer RW, Gorbach PM, Lee HY.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients

HIV Clinical Trials, 2002
The efficacy of treatment containing nonnucleoside reverse transcriptase inhibitors (NNRTIs) could be compromised in NNRTI-naïve patients already harboring a virus resistant to NNRTIs. On the contrary, hypersusceptibility to NNRTIs in patients having failed nucleoside reverse transcriptase inhibitor (NRTI)-containing regimens has been described and has
P, Clevenbergh, E, Cua, E, Dam, J, Durant, J C, Schmit, R, Boulme, J, Cottalorda, A, Beyou, J M, Schapiro, F, Clavel, P, Dellamonica   +10 more
exaly   +3 more sources